{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:37:21Z","timestamp":1790289441255,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,14]]},"DOI":"10.7759\/cureus.56168","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:26:40Z","timestamp":1710422800000},"source":"Crossref","is-referenced-by-count":3,"title":["A Narrative Review on Managing Retinopathy of Prematurity: Insights Into Pathogenesis, Screening, and Treatment Strategies"],"prefix":"10.7759","author":[{"given":"Kratika","family":"Bishnoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanisha","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapneel","family":"Mathurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m A","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet. 2013, 382:1445-57. 10.1016\/S0140-6736(13)60178-6","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/ANC.0000000000000434","article-title":"A review of oxygen physiology and appropriate management of oxygen levels in premature neonates","volume":"18","author":"Kayton A","year":"2018","unstructured":"Kayton A, Timoney P, Vargo L, Perez JA. A review of oxygen physiology and appropriate management of oxygen levels in premature neonates. Adv Neonatal Care. 2018, 18:98-104. 10.1097\/ANC.0000000000000434","journal-title":"Adv Neonatal Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23158","article-title":"Retinopathy of prematurity among very low-birth-weight infants in China: incidence and perinatal risk factors","volume":"59","author":"Wu T","year":"2018","unstructured":"Wu T, Zhang L, Tong Y, Qu Y, Xia B, Mu D. Retinopathy of prematurity among very low-birth-weight infants in China: incidence and perinatal risk factors. Invest Ophthalmol Vis Sci. 2018, 59:757-63. 10.1167\/iovs.17-23158","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apa.13350","article-title":"Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development","volume":"105","author":"Hellstr\u00f6m A","year":"2016","unstructured":"Hellstr\u00f6m A, Ley D, Hansen-Pupp I, et al.. Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development. Acta Paediatr. 2016, 105:576-86. 10.1111\/apa.13350","journal-title":"Acta Paediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000330174","article-title":"Understanding retinopathy of prematurity: update on pathogenesis","volume":"100","author":"Rivera JC","year":"2011","unstructured":"Rivera JC, Sapieha P, Joyal JS, et al.. Understanding retinopathy of prematurity: update on pathogenesis. Neonatology. 2011, 100:343-53. 10.1159\/000330174","journal-title":"Neonatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2022.11.007","article-title":"Retinopathy of prematurity: A review of pathophysiology and signaling pathways","volume":"68","author":"Fevereiro-Martins M","year":"2023","unstructured":"Fevereiro-Martins M, Marques-Neves C, Guimar\u00e3es H, Bicho M. Retinopathy of prematurity: A review of pathophysiology and signaling pathways. Surv Ophthalmol. 2023, 68:175-210. 10.1016\/j.survophthal.2022.11.007","journal-title":"Surv Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2012.12.155","article-title":"Effects of oxygen on the development and severity of retinopathy of prematurity","volume":"17","author":"Hartnett ME","year":"2013","unstructured":"Hartnett ME, Lane RH. Effects of oxygen on the development and severity of retinopathy of prematurity. J AAPOS. 2013, 17:229-34. 10.1016\/j.jaapos.2012.12.155","journal-title":"J AAPOS"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2017.11.008","article-title":"Oxidative stress in the retina: implications for retinopathy of prematurity","volume":"7","author":"Couroucli XI","year":"2018","unstructured":"Couroucli XI. Oxidative stress in the retina: implications for retinopathy of prematurity. Curr Opin Toxicol. 2018, 7:102-9. 10.1016\/j.cotox.2017.11.008","journal-title":"Curr Opin Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0036-1586109","article-title":"Role of insulinlike growth factor 1 in fetal development and in the early postnatal life of premature infants","volume":"33","author":"Hellstr\u00f6m A","year":"2016","unstructured":"Hellstr\u00f6m A, Ley D, Hansen-Pupp I, et al.. Role of insulinlike growth factor 1 in fetal development and in the early postnatal life of premature infants. Am J Perinatol. 2016, 33:1067-71. 10.1055\/s-0036-1586109","journal-title":"Am J Perinatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-023-04278-6","article-title":"Oxygen saturation levels and retinopathy of prematurity in extremely preterm infants - a case control study","volume":"23","author":"Aggarwal V","year":"2023","unstructured":"Aggarwal V, Bhatia R, Tan K. Oxygen saturation levels and retinopathy of prematurity in extremely preterm infants - a case control study. BMC Pediatr. 2023, 23:449. 10.1186\/s12887-023-04278-6","journal-title":"BMC Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.835771","article-title":"Decoupling oxygen tension from retinal vascularization as a new perspective for management of retinopathy of prematurity. New opportunities from \u03b2-adrenoceptors","volume":"13","author":"Filippi L","year":"2022","unstructured":"Filippi L, Cammalleri M, Amato R, Ciantelli M, Pini A, Bagnoli P, Dal Monte M. Decoupling oxygen tension from retinal vascularization as a new perspective for management of retinopathy of prematurity. New opportunities from \u03b2-adrenoceptors. Front Pharmacol. 2022, 13:835771. 10.3389\/fphar.2022.835771","journal-title":"Front Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett ME","year":"2012","unstructured":"Hartnett ME, Penn JS. Mechanisms and management of retinopathy of prematurity. N Engl J Med. 2012, 367:2515-26. 10.1056\/NEJMra1208129","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13020291","article-title":"Systemic cytokines in retinopathy of prematurity","volume":"13","author":"Wu PY","year":"2023","unstructured":"Wu PY, Fu YK, Lien RI, et al.. Systemic cytokines in retinopathy of prematurity. J Pers Med. 2023, 13:291. 10.3390\/jpm13020291","journal-title":"J Pers Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12049","article-title":"The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge","volume":"92","author":"Cavallaro G","year":"2014","unstructured":"Cavallaro G, Filippi L, Bagnoli P, et al.. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. 2014, 92:2-20. 10.1111\/aos.12049","journal-title":"Acta Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v5.i1.35","article-title":"Retinopathy of prematurity: past, present and future","volume":"5","author":"Shah PK","year":"2016","unstructured":"Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: past, present and future. World J Clin Pediatr. 2016, 5:35-46. 10.5409\/wjcp.v5.i1.35","journal-title":"World J Clin Pediatr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s40135-013-0028-y","article-title":"Risk factors for retinopathy of prematurity: beyond age, birth weight, and oxygen","volume":"1","author":"Mantagos IS","year":"2013","unstructured":"Mantagos IS, VanderVeen DK, Smith LEH. Risk factors for retinopathy of prematurity: beyond age, birth weight, and oxygen. Curr Ophthalmol Rep. 2013, 1:213-7. 10.1007\/s40135-013-0028-y","journal-title":"Curr Ophthalmol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2016.09.008","article-title":"IGF-1 in retinopathy of prematurity, a CNS neurovascular disease","volume":"102","author":"Liegl R","year":"2016","unstructured":"Liegl R, L\u00f6fqvist C, Hellstr\u00f6m A, Smith LE. IGF-1 in retinopathy of prematurity, a CNS neurovascular disease. Early Hum Dev. 2016, 102:13-9. 10.1016\/j.earlhumdev.2016.09.008","journal-title":"Early Hum Dev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/15.10.667","article-title":"Retinopathy of prematurity: recommendations for screening","volume":"15","author":"Jefferies A","year":"2010","unstructured":"Jefferies A. Retinopathy of prematurity: recommendations for screening. Paediatr Child Health. 2010, 15:667-74. 10.1093\/pch\/15.10.667","journal-title":"Paediatr Child Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson WM","year":"2013","unstructured":"Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013, 131:189-95. 10.1542\/peds.2012-2996","journal-title":"Pediatrics"},{"key":"ref20","article-title":"Retinopathy of prematurity: a review of current screening guidelines and treatment options","volume":"113","author":"Broxterman EC","year":"2016","unstructured":"Broxterman EC, Hug DA. Retinopathy of prematurity: a review of current screening guidelines and treatment options. Mo Med. 2016, 113:187-90.","journal-title":"Mo Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000645","article-title":"Strengthening retinopathy of prematurity screening and treatment services in Nigeria: a case study of activities, challenges and outcomes 2017-2020","volume":"6","author":"Ademola-Popoola DS","year":"2021","unstructured":"Ademola-Popoola DS, Fajolu IB, Gilbert C, et al.. Strengthening retinopathy of prematurity screening and treatment services in Nigeria: a case study of activities, challenges and outcomes 2017-2020. BMJ Open Ophthalmol. 2021, 6:e000645. 10.1136\/bmjophth-2020-000645","journal-title":"BMJ Open Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.97927","article-title":"Retinopathy of prematurity: a study of prevalence and risk factors","volume":"19","author":"Hakeem AH","year":"2012","unstructured":"Hakeem AH, Mohamed GB, Othman MF. Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr J Ophthalmol. 2012, 19:289-94. 10.4103\/0974-9233.97927","journal-title":"Middle East Afr J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14260\/jemds\/2014\/3835","article-title":"Prevalence of retinopathy of prematurity in Asian Indian babies from a tertiary care centre","volume":"17","author":"Hegde S","year":"2014","unstructured":"Hegde S, Nixon H, Vinay PG, Mendonca N, Kamath S. Prevalence of retinopathy of prematurity in Asian Indian babies from a tertiary care centre. J Evol Med Dent Sci. 2014, 17:13730-5. 10.14260\/jemds\/2014\/3835","journal-title":"J Evol Med Dent Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.03028","article-title":"Screening and surveillance for retinopathy of prematurity: a Wilson and Jungner framework approach","volume":"13","author":"Athikarisamy SE","year":"2023","unstructured":"Athikarisamy SE, Lam GC. Screening and surveillance for retinopathy of prematurity: a Wilson and Jungner framework approach. J Glob Health. 2023, 13:03028. 10.7189\/jogh.13.03028","journal-title":"J Glob Health"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0317","article-title":"Bevacizumab","volume":"15","author":"Kazazi-Hyseni F","year":"2010","unstructured":"Kazazi-Hyseni F, Beijnen JH, Schellens JH. Bevacizumab. Oncologist. 2010, 15:819-25. 10.1634\/theoncologist.2009-0317","journal-title":"Oncologist"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"Sato T","year":"2012","unstructured":"Sato T, Wada K, Arahori H, Kuno N, Imoto K, Iwahashi-Shima C, Kusaka S. Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol. 2012, 153:327-33.e1. 10.1016\/j.ajo.2011.07.005","journal-title":"Am J Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl A","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A, et al.. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet. 2019, 394:1551-9. 10.1016\/S0140-6736(19)31344-3","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2014.08.011","article-title":"Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity","volume":"41","author":"Hartnett ME","year":"2014","unstructured":"Hartnett ME. Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. Clin Perinatol. 2014, 41:925-43. 10.1016\/j.clp.2014.08.011","journal-title":"Clin Perinatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2016.12.004","article-title":"Advances in understanding and management of\u00a0retinopathy of prematurity","volume":"62","author":"Hartnett ME","year":"2017","unstructured":"Hartnett ME. Advances in understanding and management of\u00a0retinopathy of prematurity. Surv Ophthalmol. 2017, 62:257-76. 10.1016\/j.survophthal.2016.12.004","journal-title":"Surv Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.71689","article-title":"Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia","volume":"58","author":"Jalali S","year":"2010","unstructured":"Jalali S, Azad R, Trehan HS, Dogra MR, Gopal L, Narendran V. Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia. Indian J Ophthalmol. 2010, 58:509-15. 10.4103\/0301-4738.71689","journal-title":"Indian J Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-42634-7_106","article-title":"Surgical techniques in retinopathy of prematurity (ROP)","author":"Jeng-Miller K","year":"2022","unstructured":"Jeng-Miller K, Mukai S, Yonekawa Y. Surgical techniques in retinopathy of prematurity (ROP). Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert D, Miller M (ed): Springer International Publishing, Cham; 2022. 1:1-11. 10.1007\/978-3-030-42634-7_106"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158529","article-title":"New aspects on the treatment of retinopathy of prematurity: currently available therapies and emerging novel therapeutics","volume":"23","author":"Ryu J","year":"2022","unstructured":"Ryu J. New aspects on the treatment of retinopathy of prematurity: currently available therapies and emerging novel therapeutics. Int J Mol Sci. 2022, 23:8529. 10.3390\/ijms23158529","journal-title":"Int J Mol Sci"},{"key":"ref33","unstructured":"Surgeries and Procedures. Retinopathy of Prematurity (for Parents). (2023). Accessed: August 19, 2023: https:\/\/kidshealth.org\/HumanaKentucky\/en\/parents\/emmi-rop.html."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1080\/17469899.2019.1596026","article-title":"A review of treatment for retinopathy of prematurity","volume":"14","author":"Hansen ED","year":"2019","unstructured":"Hansen ED, Hartnett ME. A review of treatment for retinopathy of prematurity. Expert Rev Ophthalmol. 2019, 14:73-87. 10.1080\/17469899.2019.1596026","journal-title":"Expert Rev Ophthalmol"},{"key":"ref35","article-title":"Current ROP therapies: how laser and anti-VEGF compare","volume":"1","author":"Stuart A","year":"2014","unstructured":"Stuart A. Current ROP therapies: how laser and anti-VEGF compare. Eye Net Mag. 2014, 1:1-10.","journal-title":"Eye Net Mag"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.969861","article-title":"Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China","volume":"9","author":"Zhong Y","year":"2022","unstructured":"Zhong Y, Yang Y, Yin H, Zhao M, Li X, Liang J, Cheng Y. Evaluation of segmental scleral buckling surgery for stage 4A retinopathy of prematurity in China. Front Med (Lausanne). 2022, 9:969861. 10.3389\/fmed.2022.969861","journal-title":"Front Med (Lausanne)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-021-02095-3","article-title":"Scleral buckling surgery for stage 4A and 4B retinopathy of prematurity in critically ill neonates","volume":"42","author":"Papageorgiou E","year":"2022","unstructured":"Papageorgiou E, Riri K, Kardaras D, Grivea I, Mataftsi A, Tsironi EE, Androudi S. Scleral buckling surgery for stage 4A and 4B retinopathy of prematurity in critically ill neonates. Int Ophthalmol. 2022, 42:1093-100. 10.1007\/s10792-021-02095-3","journal-title":"Int Ophthalmol"},{"key":"ref38","unstructured":"Sclera buckling procedure - an overview. (2023). Accessed. August 19, 2023: https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/sclera-buckling-procedure."},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.4103\/tjo.tjo_102_18","article-title":"Current concepts and techniques of vitrectomy for retinopathy of prematurity","volume":"8","author":"Kusaka S","year":"2018","unstructured":"Kusaka S. Current concepts and techniques of vitrectomy for retinopathy of prematurity. Taiwan J Ophthalmol. 2018, 8:216-21. 10.4103\/tjo.tjo_102_18","journal-title":"Taiwan J Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S443810","article-title":"Vitrectomy results for stages 4 and 5 retinopathy of prematurity in Iraq","volume":"17","author":"Bahrani HM","year":"2023","unstructured":"Bahrani HM, Alhasseny KF. Vitrectomy results for stages 4 and 5 retinopathy of prematurity in Iraq. Clin Ophthalmol. 2023, 17:4033-41. 10.2147\/OPTH.S443810","journal-title":"Clin Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000783","article-title":"Complications of retinopathy of prematurity treatment","volume":"32","author":"Barnett JM","year":"2021","unstructured":"Barnett JM, Hubbard GB. Complications of retinopathy of prematurity treatment. Curr Opin Ophthalmol. 2021, 32:475-81. 10.1097\/ICU.0000000000000783","journal-title":"Curr Opin Ophthalmol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-52190-9_11","article-title":"Complications of retinopathy of prematurity treatment","author":"Wu WC","year":"2017","unstructured":"Wu WC, Kuo JZ. Complications of retinopathy of prematurity treatment. Retinopathy of Prematurity: Current Diagnosis and Management. Kychenthal BA, Dorta SP (ed): Springer International Publishing, Cham; 2017. 1:119-28. 10.1007\/978-3-319-52190-9_11"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/184558-a-narrative-review-on-managing-retinopathy-of-prematurity-insights-into-pathogenesis-screening-and-treatment-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T13:26:46Z","timestamp":1710422806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/184558-a-narrative-review-on-managing-retinopathy-of-prematurity-insights-into-pathogenesis-screening-and-treatment-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.56168","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}